일스병에서 유리체강내 베바시주맙 주입술의 효과

• 영문명: The Effect of Intravitreal Bevacizumab Injection in Eales’ Disease
• 발행기관: 대한안과학회
• 저자명: 문상원 송유미 조희윤 이병로 손준홍 박영숙,Sang Won Moon, MD, Yumi Song, MD, Hee Yoon Cho, MD, Byung Ro Lee, MD, Jun Hong Sohn, MD, Young Sook Park, MD
• 간행물 정보: 『대한안과학회지』Ophthalmological Society,volume50,number10, 1595~1599쪽, 전체 5쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2009.10.15

영문 초록

Purpose: To report on 2 cases of Eales’ disease that were successfully regressed with laser photocoagulation and intravitreal bevacizumab (Avastin; Genetech, Inc, San Francisco, California, USA) injection. Case summary: Two male patients (30 years and, 40 years of age,) with a history of recurrent vitreous hemorrhage were diagnosed with Eales’ disease. The 2 patients had peripheral retina neovascularization and active phlebitis in fundus fluorescein angiography. No other findings were observed in their eyes in the general examination. Scatter laser photocoagulation and intravitreal bevacizumab injection were performed. After 1 month follow-up, neovascularization completely regressed. There was no complication or recurrent vitreous hemorrhage at the 1 year follow up. Conclusions: Intravitreal bevacizumab injection, as combination treatment of laser photocoagulation, may be helpful in the regression of neovascularization due to Eales’ disease.

키워드

Eales’ disease, Intravitreal bevacizumab injection, Laser photocoagulation